Knight Therapeutics Inc (TSE:GUD) - Share price


Stock Report

Knight Therapeutics Inc GUD

Last Price
CAD5.66

Day Change
0.09|1.62%

As of 05/08/2022
16:00:00 EDT | CAD
Minimum 15 Minutes Delay.

Last Close5.57
Day Range5.55 - 5.68
Mkt Cap648.80Mil
52-Wk Range5.03 - 5.85
Yield %-
ISINCA4990531069
Volume112,812
P/E40.00
P/S2.64
P/CF17.08

Share Price

Financials
201920202021
More ...
Income Statement
Revenue47.46199.52243.48
Operating Income-12.66-30.00-12.83
Net Income14.5242.0715.68
Basic EPS0.100.320.13
Avg. Diluted Shares Outstanding140132125
Balance Sheet
Current Assets621.52552.10304.97
Non Current Assets683.78487.58686.92
Total Assets1,305.301,039.68991.89
Current Liabilities350.80114.06105.30
Total Liabilities---
Total Equity810.73886.24842.02
Cash Flow
Operating Cash Flow4.60-12.2144.62
Capital Expenditure-2.95-20.67-224.18
Free Cash Flow1.65-32.87-179.57

In millions, except "Basic EPS". Currency is CAD.

Company Profile

Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing innovative pharmaceutical products, consumer health products, and medical devices in Canada and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

766
Key Stats
More ...
Price/Earning TTM-92.83
Price/Book0.77
Price/Sales TTM2.59
Rev Growth (3 year avg)169.06
EPS Growth (3 year avg)-
Operating Margin % TTM-5.27
Net Margin % TTM6.44
ROE TTM1.81
Debt/Equity0.02
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2022 Morningstar. All rights reserved.